The Academy of Managed Care Pharmacy (AMCP) is writing to express concerns with specific provisions of Assembly Bill 679 and Senate Bill 575. This legislation would regulate biological products and substitution of interchangeable biological products when dispensed by pharmacists.
Press Release: Academy of Managed Care Pharmacy (AMCP) CEO Susan A. Cantrell, RPh, CAE, issued the following statement on President Trump’s budget proposal for fiscal year 2019.
AMCP CEO Blog: The FDA approved 46 novel drugs in 2017, a 21-year high. However, it could take as long as six months for some of these groundbreaking medicines to reach patients.
Press Release: The Biologics and Biosimilars Collective Intelligence Consortium is pleased to announce that Cate Lockhart, PharmD, PhD, has been appointed BBCIC Program Director.
The undersigned organizations write to voice our strong support for the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (S. 974/H.R. 2212) and encourage Congress to pass this important, bipartisan legislation as soon as possible.
February 2018 News & Views: PIE Act Is Now Before the Full E&C Committee; CEO Blog: PIE Act Addresses Lag Between FDA Approval, Patient Access; VIDEO: Academy Urges Passage of PIE Act
Leg-Reg Briefing February 2018: PIE Act Before Full House Energy & Commerce Committee AMCP Signs Joint Leer Supporting CREATES Act Bipartisan Budget Act of 2018 Addresses Part D Coverage Gap